MEDICAL PRODUCTS — TURKEY-ORIGIN SOURCING
Medical Products Sourcing from Turkey
Independent buyer-side procurement governance for international buyers sourcing medical products and devices from Turkey. Structure your sourcing before supplier commitment. No trading. No supplier representation. No commissions.
TURKEY’S POSITION IN THIS SECTOR
Why buyers source medical products from Turkey.
Turkey has a growing medical device and healthcare products manufacturing base with documented export activity to EU, MENA, and USA markets across disposables, diagnostic equipment, orthopaedic products, surgical instruments, and hospital supplies. The sector requires the highest level of compliance verification among all sourcing categories. Understanding both production capabilities and sector-specific regulatory risks is essential before any sourcing engagement begins.
- Established production capability across medical disposables, surgical instruments, orthopaedic products, hospital furniture, and diagnostic equipment categories
- Manufacturers with documented EU and MENA export activity exist across multiple medical product categories
- Some manufacturers hold ISO 13485 quality management system certification and EU MDR Notified Body involvement
- Cost-competitive production capability for standard medical disposables and hospital supply categories
- Geographic proximity supports competitive logistics for EU and MENA buyers
- Private label and OEM production available where quality management systems and regulatory compliance are independently confirmed
- ISO 13485 certificates frequently misrepresented in scope — the certificate may not cover the specific product category or production process being sourced
- EU MDR 2017/745 Notified Body certificate validity and scope not confirmed — MDD-era certificates must not be accepted at face value; transitional status requires independent confirmation
- Manufacturer vs trader distinction particularly difficult to establish in medical products — trading intermediaries present with manufacturer-level compliance documentation
- FDA QMSR requirements not confirmed for USA-bound sourcing engagements
- Sterilisation process validation documentation rarely confirmed before commercial engagement begins
- Labelling compliance for destination market language and regulatory requirements not confirmed before order placement
- Established production capability across medical disposables, surgical instruments, orthopaedic products, hospital furniture, and diagnostic equipment categories
- Manufacturers with documented EU and MENA export activity exist across multiple medical product categories
- Some manufacturers hold ISO 13485 quality management system certification and EU MDR Notified Body involvement
- Cost-competitive production capability for standard medical disposables and hospital supply categories
- Geographic proximity supports competitive logistics for EU and MENA buyers
- Private label and OEM production available where quality management systems and regulatory compliance are independently confirmed
- ISO 13485 certificates frequently misrepresented in scope — the certificate may not cover the specific product category or production process being sourced
- EU MDR 2017/745 Notified Body certificate validity and scope not confirmed — MDD-era certificates must not be accepted at face value; transitional status requires independent confirmation
- Manufacturer vs trader distinction particularly difficult to establish in medical products — trading intermediaries present with manufacturer-level compliance documentation
- FDA QMSR requirements not confirmed for USA-bound sourcing engagements
- Sterilisation process validation documentation rarely confirmed before commercial engagement begins
- Labelling compliance for destination market language and regulatory requirements not confirmed before order placement
In medical sourcing, an expired certificate is a patient safety risk.
Certificate scope, Notified Body certificate validity, and manufacturer identity all require independent confirmation before any medical product sourcing engagement progresses. Compliance gaps in this sector carry consequences beyond commercial risk.
REQUIREMENTS BY TARGET MARKET
Turkey does not change. Your target market does.
Medical product compliance requirements vary significantly by destination market and device classification. EU MDR, US FDA, and MENA import requirements each impose different obligations. These requirements must be fully mapped before supplier shortlisting begins.
- EU MDR 2017/745 — mandatory for medical devices; MDD-era certificates must not be accepted at face value
- ISO 13485:2016 — quality management system; scope must cover the specific product category
- Notified Body involvement required for Class IIa, IIb, and III devices
- EU Authorised Representative required for non-EU manufacturers
- CE marking under MDR framework with current, traceable certificate
- EUDAMED obligations where applicable and operational
- FDA QMSR — Quality Management System Regulation, aligned with ISO 13485, effective February 2, 2026
- 510(k) clearance, PMA approval, or De Novo classification depending on device class
- FDA facility registration and device listing for US-distributed products
- US Agent requirement for foreign manufacturers
- Labelling compliance with FDA requirements including intended use, indications, and warnings
- Import documentation and Importer of Record requirements
- Country-specific medical device registration — requirements vary significantly by market
- SFDA registration for Saudi Arabia; DOH and MOHAP for UAE
- ISO 13485 certification typically required as registration baseline
- CE marking under EU MDR often accepted as technical documentation reference
- Arabic labelling and country-specific IFU requirements where applicable
- Health authority import permit requirements vary by country and device category
- EU MDR alignment applicable in EU-candidate markets
- CE marking under MDR framework where EU alignment applies
- ISO 13485 certification as quality management baseline
- Import documentation and conformity certificates
- Country-specific medical device registration where applicable
- Technical documentation in relevant language where required
COMPLIANCE TRAPS
The two most critical compliance failures in Turkey-origin medical product sourcing.
These are recurring sourcing risks in electrical and lighting projects. Most appear after supplier selection rather than before it, and both can be reduced through structured verification before commercial engagement begins.
ISO 13485 scope mismatch — certificate does not cover the specific product
Expired or MDD-era Notified Body certificate — no longer valid for EU MDR
A Turkish medical product supplier presents an ISO 13485 certificate. The certificate is scoped to a different product category, a different production process, or a different site than the one that will produce the goods being sourced. ISO 13485 certification is scoped to specific product categories and manufacturing processes — a certificate covering one product type does not extend to another. Scope confirmation against the specific product category, production site, and contracting legal entity must be completed before any medical product sourcing engagement progresses.
A supplier presents a Notified Body certificate for EU market access. The certificate was issued under the Medical Devices Directive (MDD 93/42/EEC). MDD-era certificates should not be accepted at face value — their transitional validity, device scope, and MDR transition conditions must be independently confirmed before EU-bound sourcing progresses. Alternatively, an MDR certificate may have lapsed or the Notified Body may have had its designation suspended. EU MDR 2017/745 Notified Body certificate validity, scope, and Notified Body designation status must be independently confirmed before any EU-bound medical product sourcing begins.
WHERE SOURCING FAILS IN THIS CATEGORY
What buyers sourcing medical products from Turkey actually face.
Medical product sourcing failures in Turkey carry consequences beyond commercial risk. They occur when certification scope, manufacturer identity, and regulatory framework compliance are assumed rather than independently verified before engagement begins.
Buyers accept ISO 13485 certification as evidence of quality management compliance without confirming the scope against the specific product, production process, and site. A certificate that exists for a different product category does not confirm compliance for the product being sourced. Scope confirmation is the first verification requirement — not an optional step.
Turkey-origin medical product trading intermediaries frequently present with ISO 13485 certificates, CE marking documentation, and MDR involvement claims that belong to the manufacturers they source from. The contracting entity and the manufacturing entity with regulatory authorisation must be confirmed as the same. In medical products, this distinction carries regulatory and patient safety implications — not just commercial risk.
EU MDR 2017/745 replaced MDD 93/42/EEC and AIMD 90/385/EEC. MDD-era certificates should not be accepted at face value — transitional validity, device scope, and MDR transition conditions must be independently confirmed. A supplier presenting an MDD-era Notified Body certificate as evidence of EU market compliance is presenting documentation whose current validity requires independent verification. EU MDR Notified Body certificate status must be confirmed before any EU-bound medical product order is placed.
For sterile medical products, sterilisation process validation documentation is rarely confirmed before commercial engagement begins. For all medical products, destination market labelling requirements — including language, symbols, and regulatory information — are frequently not confirmed before order placement. Both gaps create regulatory exposure that surfaces at import or distribution stage — after commercial commitment has been made.
COMPLIANCE & CERTIFICATION MAP
What medical product buyers need confirmed before supplier engagement.
The certifications and regulatory requirements below are the most commonly required — and the most frequently misrepresented — in Turkey-origin medical product sourcing. Requirements vary by device classification and destination market. Each must be confirmed before commercial engagement begins.
What it covers
Quality management system framework specific to medical device design, production, installation, and servicing. Required by EU MDR and most destination market regulatory frameworks as a baseline quality standard for medical device manufacturers.
Common gap in Turkey sourcing
Certificate scoped to a different product category, process, or site than the one producing the goods being sourced; certificate held by a different legal entity than the contracting supplier. Scope must be confirmed against the contracting entity and the specific product category before shortlisting.
What it covers
Mandatory regulatory framework for medical devices placed on the EU market. Requires Notified Body involvement for Class IIa, IIb, and III devices. EU Authorised Representative establishment required for non-EU manufacturers.
Common gap in Turkey sourcing
MDD-era certificates presented as valid EU compliance — they are not without confirming transitional status. Notified Body certificate lapsed or designation suspended; EU Authorised Representative not confirmed before engagement begins. MDR compliance status must be verified at device and entity level.
What it covers
Confirms conformity with EU MDR requirements for the specific device. CE marking under the superseded MDD framework should not be accepted at face value without confirming transitional validity and MDR applicability for the specific device classification and intended use.
Common gap in Turkey sourcing
CE marking present under superseded MDD framework; Notified Body certificate not current or not traceable to the specific device and contracting entity. CE marking must be confirmed as MDR-compliant, current, and traceable to the contracting legal entity before any EU-bound medical device order is placed.
What it covers
EU MDR requires registration of manufacturers, authorised representatives, and devices in EUDAMED before devices can be placed on the EU market. The system provides traceability across the medical device supply chain.
Common gap in Turkey sourcing
Turkish manufacturers or their EU Authorised Representatives may not have completed EUDAMED registration for the specific device or device category. EUDAMED registration status must be confirmed before any EU-bound medical device sourcing engagement proceeds.
What it covers
510(k) clearance or Premarket Approval (PMA) is required before most medical devices can be legally marketed in the USA. 510(k) applies to Class II devices demonstrating substantial equivalence to a predicate device; PMA applies to Class III devices. CE marking is not an equivalent or substitute.
Common gap in Turkey sourcing
Turkish medical device manufacturers exporting to the EU rarely hold simultaneous FDA clearance. CE marking is frequently assumed sufficient for USA market access — it is not. FDA clearance status must be confirmed for the specific device and intended use before any USA-bound medical device sourcing engagement begins.
What it covers
Updated US FDA quality management system regulation aligned with ISO 13485 — replaces 21 CFR Part 820 QSR for medical devices distributed in the USA. Effective February 2, 2026.
Common gap in Turkey sourcing
Suppliers may not be aware of QMSR transition requirements; compliance position not confirmed for USA-bound sourcing engagements. ISO 13485 certification alone does not confirm QMSR compliance — specific QMSR requirements must be confirmed with the supplier.
What it covers
Manufacturing practice standards covering facility, process, documentation, and quality controls for medical product production. GMP compliance is a prerequisite for regulatory approval in all major markets — it is a facility-level requirement, not a document.
Common gap in Turkey sourcing
GMP compliance assumed from ISO 13485 certification; actual production facility GMP compliance not independently confirmed. ISO 13485 is a quality management system standard — it does not automatically confirm facility-level GMP compliance.
What it covers
Documented validation confirming that the sterilisation process consistently achieves the required sterility assurance level for the specific product. Required for all sterile medical products across all markets.
Common gap in Turkey sourcing
Sterilisation validation documentation not requested or reviewed before commercial engagement; process validation not confirmed for the specific product configuration. Validation documentation must be confirmed before any sterile medical product sourcing commitment is made.
What it covers
Official documentation confirming country of origin for customs clearance and preferential tariff purposes. EUR.1 applies under Turkey-EU customs union arrangements. For medical products, origin documentation is also relevant for import licensing and market authorisation purposes.
Common gap in Turkey sourcing
Document type required varies by destination market. Buyers frequently do not specify origin documentation requirements before order placement, creating customs clearance delays at import stage.
What it covers
QMS framework specific to medical device design, production, installation, and servicing. Required by EU MDR and most destination market frameworks.
Common gap
Certificate scoped to a different product category, process, or site; held by a different legal entity than the contracting supplier.
What it covers
Mandatory regulatory framework for medical devices placed on the EU market. Requires Notified Body involvement for Class IIa, IIb, and III devices.
Common gap
MDD-era certificates presented as valid EU compliance; Notified Body certificate lapsed; EU Authorised Representative not confirmed.
What it covers
Confirms conformity with EU MDR for the specific device. CE marking under the superseded MDD must not be accepted at face value without confirming MDR transitional validity.
Common gap
CE marking present under superseded MDD; Notified Body certificate not current or not traceable to the contracting entity.
What it covers
EU MDR requires registration of manufacturers, authorised representatives, and devices in EUDAMED before devices can be placed on the EU market.
Common gap
Manufacturers or EU Authorised Representatives may not have completed EUDAMED registration for the specific device. Registration status must be confirmed before EU-bound sourcing proceeds.
What it covers
510(k) clearance or PMA is required before most medical devices can be legally marketed in the USA. CE marking is not an equivalent or substitute.
Common gap
Turkish manufacturers exporting to the EU rarely hold simultaneous FDA clearance. CE marking assumed sufficient for USA market access — it is not.
What it covers
Updated FDA QMS regulation aligned with ISO 13485 — replaces 21 CFR Part 820 QSR. Effective February 2, 2026.
Common gap
Suppliers may not be aware of QMSR transition requirements. ISO 13485 alone does not confirm QMSR compliance.
What it covers
Facility, process, documentation, and quality controls for medical product production. Required across all major markets — a facility-level requirement, not a document.
Common gap
GMP compliance assumed from ISO 13485 certification; actual production facility compliance not independently confirmed.
What it covers
Documented validation confirming the sterilisation process consistently achieves the required sterility assurance level for the specific product.
Common gap
Sterilisation validation documentation not requested before commercial engagement; process validation not confirmed for the specific product configuration.
What it covers
Official documentation confirming country of origin for customs clearance and preferential tariff purposes. For medical products, also relevant for import licensing and market authorisation.
Common gap
Document type required varies by destination market. Buyers frequently do not specify requirements before order placement.
KEY VERIFICATION AREAS
What we verify in medical product sourcing.
These are the specific verification points applied in every medical product sourcing engagement. Each area addresses a known structural gap in Turkey-origin medical supply chains. In this sector, verification is not optional — it is the minimum standard before any supplier advances to the RFQ stage.
WHAT YOU RECEIVE
Structured outputs at the end of each engagement stage.
Every medical product sourcing engagement produces documented outputs at each stage. These are not verbal assessments — they are structured deliverables that inform your sourcing decisions before any supplier advances to commercial engagement.
SCOPE BOUNDARIES
What this engagement does not cover.
Clarity on scope boundaries is part of the governance structure. In medical product sourcing, scope boundaries are particularly important. The following activities are outside the scope of Hana Solution’s medical product sourcing engagement.
HOW HANA SOLUTION WORKS IN THIS SECTOR
Governance applied to medical product sourcing from Turkey.
The same six-stage governance sequence is applied to every engagement. In medical product sourcing, ISO 13485 scope confirmation, EU MDR Notified Body certificate validity, and manufacturer identity are the highest-priority validation steps — without exception.
Sourcing Direction & Strategy
Device classification, regulatory framework, and destination market compliance requirements defined before any supplier contact begins.
Supplier Mapping & Shortlisting
Turkey-origin medical product manufacturers identified against defined criteria. Trading intermediaries separated from regulated manufacturers before shortlist formation.
Supplier Verification & Risk Screening
Registry status, ISO 13485 scope, MDR Notified Body certificate validity, GMP compliance, and counterparty risk assessed for each shortlisted supplier.
RFQ Governance & Quotation Analysis
Product specification and regulatory documentation requirements standardised across suppliers before RFQ is issued. Quotations normalised for scope and Incoterms before price assessment begins.
Production Monitoring & Factory Visits
Production milestones tracked independently. GMP compliance and specification adherence monitored during active orders.
Shipment Process Management
Export document set reviewed and destination import requirements confirmed before departure.
Sourcing Direction & Strategy
Device classification, regulatory framework, and destination market compliance requirements defined before any supplier contact begins.
Supplier Mapping & Shortlisting
Turkey-origin medical product manufacturers identified against defined criteria. Trading intermediaries separated from regulated manufacturers before shortlist formation.
Supplier Verification & Risk Screening
Registry status, ISO 13485 scope, MDR Notified Body certificate validity, GMP compliance, and counterparty risk assessed for each shortlisted supplier.
RFQ Governance & Quotation Analysis
Product specification and regulatory documentation requirements standardised before RFQ is issued. Quotations normalised for scope and Incoterms before price assessment begins.
Production Monitoring & Factory Visits
Production milestones tracked independently. GMP compliance and specification adherence monitored during active orders.
Shipment Process Management
Export document set reviewed and destination import requirements confirmed before departure.
RELATED SOLUTIONS
Each service is available as a standalone engagement.
You do not need to engage the full governance sequence. Start where your medical product sourcing situation requires.
Sourcing Direction & Strategy
Define device classification, regulatory framework, and sourcing structure before any supplier contact begins.
View Service → Step 02Supplier Mapping & Shortlisting
Identify Turkey-origin regulated medical manufacturers. Trading intermediaries identified and separated before shortlist formation.
View Service → Step 03Supplier Verification & Risk Screening
ISO 13485 scope confirmation, MDR Notified Body certificate review, GMP facility assessment, and counterparty risk screening before commercial engagement.
View Service → Step 04RFQ Governance & Quotation Analysis
Regulatory documentation requirements standardised. Quotations normalised for scope and Incoterms before price comparison begins.
View Service → Step 05Production Monitoring & Factory Visits
Independent milestone tracking, GMP compliance monitoring, and pre-shipment coordination for active medical product orders.
View Service → Step 06Shipment Process Management
CE marking documentation, ISO 13485, sterilisation records, and destination regulatory compliance confirmed in shipment set before departure.
View Service →Define device classification, regulatory framework, and sourcing structure before any supplier contact begins.
View Service →Identify Turkey-origin regulated medical manufacturers. Trading intermediaries identified and separated before shortlist formation.
View Service →ISO 13485 scope confirmation, MDR Notified Body certificate review, GMP facility assessment, and counterparty risk screening before commercial engagement.
View Service →Regulatory documentation requirements standardised. Quotations normalised for scope and Incoterms before price comparison begins.
View Service →Independent milestone tracking, GMP compliance monitoring, and pre-shipment coordination for active medical product orders.
View Service →CE marking documentation, ISO 13485, sterilisation records, and destination regulatory compliance confirmed in shipment set before departure.
View Service →FREQUENTLY ASKED QUESTIONS
What buyers ask before sourcing medical products from Turkey.
Are MDD certificates still valid for placing medical devices on the EU market?
How do I confirm that a Turkish supplier's ISO 13485 certificate covers my product?
What does FDA QMSR mean for medical products sourced from Turkey?
Can Hana Solution verify a Turkish medical product supplier we have already been working with?
Does Hana Solution represent or recommend specific medical product suppliers?
Are MDD certificates still valid for placing medical devices on the EU market?
START HERE
Start medical product sourcing with structure before negotiation.
Submit your sourcing requirements and target market. We establish the sourcing structure, map regulatory compliance requirements, and confirm whether a controlled engagement is the right next step — before supplier contact begins.